Rogers Hobart L, Marshall Joanne, Bock Jeremy, Dowling Thomas C, Feller Erika, Robinson Shawn, Gottlieb Stephen S
University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
J Card Fail. 2008 Feb;14(1):1-5. doi: 10.1016/j.cardfail.2007.09.007.
This study was designed to evaluate the consequences of ultrafiltration (UF) and standard intravenous diuretic (furosemide) therapy on glomerular filtration rate (GFR) and renal plasma flow in patients with acute decompensated heart failure.
It has been hypothesized that treatment with diuretics may worsen renal function as the result of systemic neurohormonal activation and direct renal vascular effects. UF also removes fluid, but its actions on intrarenal hemodynamics, and therefore renal function, are unknown.
Patients hospitalized for acute decompensated heart failure with an ejection fraction less than 40% and two or more signs of hypervolemia were randomized to receive UF or intravenous diuretics. Urine output, GFR (as measured by iothalamate), and renal plasma flow (as measured by para-aminohippurate) were assessed before fluid removal and after 48 hours.
Nineteen patients (59 +/- 16 years, 68% were male) were randomized to receive UF (n = 9) or intravenous diuretics (n = 10). The change in GFR (-3.4 +/- 7.7 mL/min vs. -3.6 +/- 11.5 mL/min; P = .966), renal plasma flow (26.6 +/- 62.7 mL/min vs. 16.1 +/- 42.0 mL/min; P = .669), and filtration fraction (-6.9 +/- 13.6 mL/min vs. -3.9 +/- 13.6 mL/min; P = .644) after treatment were not significantly different between the UF and furosemide treatment groups, respectively. There was no significant difference in net 48-hour fluid removal between the groups (-3211 +/- 2345 mL for UF and -2725 +/- 2330 mL for furosemide, P = .682). UF removed 3666 +/- 2402 mL. Urine output during 48 hours was significantly greater in the furosemide group (5786 +/- 2587 mL) compared with the UF group (2286 +/- 915 mL, P < .001).
During a 48-hour period, UF did not cause any significant differences in renal hemodynamics compared with the standard treatment of intravenous diuretics.
本研究旨在评估超滤(UF)和标准静脉利尿剂(呋塞米)治疗对急性失代偿性心力衰竭患者肾小球滤过率(GFR)和肾血浆流量的影响。
有假设认为,利尿剂治疗可能因全身神经激素激活和直接肾血管效应而导致肾功能恶化。超滤也可清除液体,但其对肾内血流动力学以及肾功能的作用尚不清楚。
因急性失代偿性心力衰竭住院、射血分数低于40%且有两种或更多高血容量体征的患者被随机分为接受超滤或静脉利尿剂治疗。在液体清除前和48小时后评估尿量、GFR(通过碘他拉酸盐测量)和肾血浆流量(通过对氨基马尿酸测量)。
19例患者(年龄59±16岁,68%为男性)被随机分为接受超滤治疗组(n = 9)或静脉利尿剂治疗组(n = 10)。治疗后,超滤组和呋塞米治疗组的GFR变化(-3.4±7.7 mL/分钟对-3.6±11.5 mL/分钟;P = 0.966)、肾血浆流量变化(26.6±62.7 mL/分钟对16.1±42.0 mL/分钟;P = 0.669)和滤过分数变化(-6.9±13.6 mL/分钟对-3.9±13.6 mL/分钟;P = 0.644)分别无显著差异。两组间48小时净液体清除量无显著差异(超滤组为-3211±2345 mL,呋塞米组为-2725±2330 mL,P = 0.682)。超滤清除量为3666±2402 mL。呋塞米组48小时尿量(5786±2587 mL)显著多于超滤组(2286±915 mL,P < 0.001)。
在48小时期间,与标准静脉利尿剂治疗相比,超滤对肾血流动力学未造成任何显著差异。